abrdn European Logistics Income (ASLI) Competitors

GBX 61.03
-0.17 (-0.28%)
(As of 05:15 AM ET)

ASLI vs. IBT, RSE, CGL, ADIG, BGUK, MNL, IIG, JUSC, MNP, and CCJI

Should you be buying abrdn European Logistics Income stock or one of its competitors? The main competitors of abrdn European Logistics Income include International Biotechnology (IBT), Riverstone Energy (RSE), Castelnau Group (CGL), abrdn Diversified Income & Growth (ADIG), Baillie Gifford UK Growth Trust (BGUK), Manchester & London Investment Trust (MNL), Intuitive Investments Group (IIG), JPMorgan US Smaller Companies Investment Trust (JUSC), Martin Currie Global Portfolio (MNP), and CC Japan Income & Growth Trust (CCJI). These companies are all part of the "asset management" industry.

abrdn European Logistics Income vs.

International Biotechnology (LON:IBT) and abrdn European Logistics Income (LON:ASLI) are both small-cap financial services companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

International Biotechnology has a net margin of 84.61% compared to International Biotechnology's net margin of -196.34%. abrdn European Logistics Income's return on equity of 15.33% beat International Biotechnology's return on equity.

Company Net Margins Return on Equity Return on Assets
International Biotechnology84.61% 15.33% 9.20%
abrdn European Logistics Income -196.34%-18.70%1.88%

52.1% of International Biotechnology shares are owned by institutional investors. Comparatively, 73.2% of abrdn European Logistics Income shares are owned by institutional investors. 4.7% of International Biotechnology shares are owned by company insiders. Comparatively, 8.1% of abrdn European Logistics Income shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

abrdn European Logistics Income has a consensus target price of GBX 80, indicating a potential upside of 31.08%. Given International Biotechnology's higher probable upside, analysts plainly believe abrdn European Logistics Income is more favorable than International Biotechnology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
International Biotechnology
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
abrdn European Logistics Income
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

International Biotechnology pays an annual dividend of GBX 28 per share and has a dividend yield of 4.3%. abrdn European Logistics Income pays an annual dividend of GBX 5 per share and has a dividend yield of 8.2%. International Biotechnology pays out 2,666.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. abrdn European Logistics Income pays out -2,941.2% of its earnings in the form of a dividend. abrdn European Logistics Income is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, International Biotechnology and International Biotechnology both had 1 articles in the media. abrdn European Logistics Income's average media sentiment score of 0.00 equaled International Biotechnology'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
International Biotechnology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
abrdn European Logistics Income
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

International Biotechnology has higher revenue and earnings than abrdn European Logistics Income. abrdn European Logistics Income is trading at a lower price-to-earnings ratio than International Biotechnology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
International Biotechnology£50.96M4.96£43.12M£1.05615.24
abrdn European Logistics Income£41.66M6.04-£81.80M-£0.17-359.00

International Biotechnology has a beta of 0.18, indicating that its share price is 82% less volatile than the S&P 500. Comparatively, abrdn European Logistics Income has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500.

International Biotechnology received 110 more outperform votes than abrdn European Logistics Income when rated by MarketBeat users. Likewise, 77.71% of users gave International Biotechnology an outperform vote while only 59.09% of users gave abrdn European Logistics Income an outperform vote.

CompanyUnderperformOutperform
International BiotechnologyOutperform Votes
136
77.71%
Underperform Votes
39
22.29%
abrdn European Logistics IncomeOutperform Votes
26
59.09%
Underperform Votes
18
40.91%

Summary

International Biotechnology beats abrdn European Logistics Income on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASLI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ASLI vs. The Competition

Metricabrdn European Logistics IncomeAsset Management IndustryFinancial SectorLON Exchange
Market Cap£251.55M£745.95M£2.99B£1.43B
Dividend Yield8.13%13.27%4.59%11.85%
P/E Ratio-359.00916.23472.151,676.73
Price / Sales6.0413,729.382,532.78303,020.81
Price / Cash6.9179.6448.2432.84
Price / Book0.661.751.572.71
Net Income-£81.80M£49.00M£373.13M£175.09M
7 Day Performance4.15%0.66%0.73%0.89%
1 Month Performance1.72%3.60%3.36%4.13%
1 Year Performance-24.00%5.04%16.41%9.01%

abrdn European Logistics Income Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IBT
International Biotechnology
0 of 5 stars
GBX 632.40
-0.4%
N/A-4.2%£247.52M£50.96M602.28N/A
RSE
Riverstone Energy
0 of 5 stars
GBX 915.02
-1.3%
N/A+66.7%£248.43M£2.72M653.59N/A
CGL
Castelnau Group
0 of 5 stars
GBX 78.50
flat
N/A+5.3%£250.13M£1.99M-2,616.67N/A
ADIG
abrdn Diversified Income & Growth
0 of 5 stars
GBX 80.20
0.0%
N/A-7.6%£241.61M£-7,390,000.00-3,990.00N/APositive News
Gap Up
BGUK
Baillie Gifford UK Growth Trust
0 of 5 stars
GBX 172.86
+0.8%
N/A+5.0%£253.55M£3.08M16,950.00N/A
MNL
Manchester & London Investment Trust
0 of 5 stars
GBX 634
+0.6%
N/A+64.0%£254.81M£107.72M244.79N/A
IIG
Intuitive Investments Group
0 of 5 stars
GBX 126.34
+0.3%
N/A+1,900.0%£255.57M£-2,440,000.00-293.815Gap Up
JUSC
JPMorgan US Smaller Companies Investment Trust
0 of 5 stars
GBX 408.96
+0.6%
N/A+13.1%£256.50M£15.63M2,271.98N/A
MNP
Martin Currie Global Portfolio
0 of 5 stars
GBX 374.08
-0.2%
N/A+10.4%£257.10M£28.46M1,068.79N/ADividend Announcement
CCJI
CC Japan Income & Growth Trust
0 of 5 stars
GBX 194.35
+1.0%
N/A+23.2%£261.85MN/A2,159.44N/APositive News

Related Companies and Tools

This page (LON:ASLI) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners